Clinical Trials Browser

Terminated × Immunoglobulin Light-chain Amyloidosis × 30 days × Clear all

NCT05839626 2026-05-27

A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma